USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
SYNERGENE THERAPEUTICS, INC.
Address:
9812 Falls Road, Suite 114
Potomac, MD 20854
Phone:
(202) 687-0356
URL:
N/A
EIN:
522083516
DUNS:
072898005
Number of Employees:
3
Woman-Owned?:
Yes
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $498,331.00 1
STTR Phase I $1,116,966.00 6
STTR Phase II $1,794,326.00 2

Award List:

IMMUNOLIPOSOME MEDIATED GENE THERAPY FOR PROSTATE CANCER

Award Year / Program / Phase:
1999 / STTR / Phase I
Award Amount:
$138,625.00
Agency:
HHS
Principal Investigator:
Chang
Research Institution:
Georgetown University
RI Contact:
N/A
Abstract:
N/a

A Tumor-Specific Nanoimmunocomplex Markedly Improves MR Imaging

Award Year / Program / Phase:
2006 / STTR / Phase I
Award Amount:
$478,857.00
Agency:
HHS
Principal Investigator:
Research Institution:
GEORGETOWN UNIVERSITY
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): The low rate of cure of pancreatic carcinoma is an important health problem. The American Cancer Society estimates that 32,000 Americans will be diagnosed with carcinoma of the pancreas in 2005, and 31,800 will die. Pancreatic cancer is the fourth leading causeā€¦ More

TAS::75 0849::TAS - SYNERGENE, INC SBIR PHASE II OPTION PERIOD

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$498,331.00
Agency:
HHS
Principal Investigator:
Raj Bawa – 202-687-0356
Abstract:
SBIR Phase II to develop a LYOPHILLIZED form of Optimized scL-gad-d complex